Pub. Date : 2022 May 13
PMID : 35551463
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | The approval of BCR::ABL1 tyrosine kinase inhibitors (TKI) such as imatinib, dasatinib, nilotinib and ponatinib marked a milestone in targeted therapy only for a subset of patients carrying the translocation t(9;22)(q34;q11). | ponatinib | ABL proto-oncogene 1, non-receptor tyrosine kinase | Homo sapiens |